Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a Locations section with Massachusetts site details and updated the revision to v3.3.3; removed the older Massachusetts Locations entry and the HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoNo Change Detected
- Check44 days agoChange DetectedPublication section wording updated to clarify that PubMed-listed publications are automatically populated and to note revision numbers (v3.3.2 vs v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page no longer displays the government funding status notice that warned about potential delays in updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedUpdates are limited to cosmetic and layout changes and do not affect core study information such as design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check102 days agoChange Detected- Added a new page revision tag (v3.1.0). - Removed a specific medical condition term (Undifferentiated pleomorphic sarcoma).SummaryDifference0.1%

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.